The global Continence Care market size was estimated at USD 14.28 billion in 2021 and is expected to surpass around USD 26.1 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2022 to 2030.
Continence Care Market: Overview
Continence Care Market: Key Drivers
Report Scope of the Continence Care Market
Report Coverage |
Details |
Market Size |
US$ 14.28 Billion by 2030 |
Growth Rate |
CAGR of 5.9% from 2022 to 2030 |
Largest Market |
North America |
Fastest Growing Market |
Asia Pacific |
Base Year |
2021 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Product , Indication, End-user, and Region, |
Companies Mentioned |
ABENA A/S, Atlantic Therapeutics, Attends Healthcare Products, Inc., B. Braun Melsungen AG Beambridge Medical Ltd., Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast A/S, ConvaTec Group plc, Drylock Technologies, Hollister Incorporated, InControl Medical LLC, Kimberly-Clark Corporation, Optimum Medical Limited, Pacey MedTech Ltd., Renew Medical, Inc., Uresta, Urocare Products, Inc., Vesiflo, Inc. |
Minimally Invasive OTC Continence Care Devices Improving Patient Outcomes
The rise in demand for minimally invasive surgery and devices to minimize complications is growing prominent in the continence care market. These devices help to prevent bladder injury and increase rates of improved product outcomes, which help to reduce hospitalization and treatment costs. For instance, the non-implantable electrical stimulation devices for pelvic floor are comparatively cheaper than implantable devices.
Companies in the continence care market are boosting R&D capabilities to increase the availability of over-the-counter (OTC) products that are FDA approved and ideal for home care. Patented home continence care devices are boosting the credibility of med-tech companies. There is a demand for devices that help to treat stress, urge, mixed urinary incontinence, and bowel incontinence.
Stakeholders Overcoming Product Distribution Bottlenecks During Coronavirus Pandemic
Services for continence care in healthcare facilities have been altered due to the coronavirus pandemic. Telephone consultations are gaining prominence in the continence care market. However, in some cases services have either stopped and have reduced in number due to the pandemic. Nevertheless, healthcare companies are increasing efforts to maintain robust supply of products to prevent interruptions in providing continence care in healthcare facilities and in home setting.
Companies in the continence care market are working at breakneck speeds to maintain continued production activities and meet demands of children, elderly, and people with learning disabilities. Suppliers and manufacturers are taking efforts to overcome bottlenecks in transport & distribution to ensure continuous supply of products & continence care devices.
Availability of Alternative Treatment and Management Methods Affects Device Sales
The availability of alternative treatment and management methods such as incontinence pads and therapeutic drugs such as muscarinic receptor antagonists are affecting sales of continence care devices. Thus, apart from devices including urinary catheters and urine drainage bags, manufacturers should diversify their production in alternative treatment and management products such as absorbable underwear and anticholinergic/antispasmodic agents to expand their revenue streams.
Companies in the continence care market should extend their production in OTC products such as tampons that are useful for temporary management of urinary incontinence among all age groups.
Supportive Reimbursement Policies in U.S. Generating Revenue Streams for Healthcare Companies
North America, followed by Europe and Asia Pacific, is expected to dictate the highest revenue share in the continence care market during the forecast period. This is evident, owing to favorable medical reimbursement policies for continence care products in developed countries such as the U.S., the U.K. and Australia, among others. Healthcare companies are investing in improving the infrastructure of developing economies in Asia Pacific owing to gradually increasing disposable income of people.
Recently electrical stimulation devices have been considered as the necessary treatment devices by the Centers for Medicare and Medicare Services (CMS) in the U.S. Such trends are increasing the consumption of these devices and generating new avenues for market players. Reimbursement for the application of electrical stimulation (manual) for pelvic floor for 15 minutes procedure is covered under the CPT code of 97032 by the U.S. reimbursement programs.
Non-implantable and Wearable Electrical Stimulation Devices Offer Advantages over Implantable Devices
Only a small number of companies are currently operating in the non-implantable and wearable electrical stimulation devices market landscape. Thus, startups and emerging market players should capitalize on this opportunity to boost research in developing non-implantable and wearable electrical stimulation devices.
Non-implantable and wearable electrical stimulation devices offer several advantages over implantable ones. Hence, manufacturers in the continence care market are increasing output capacities in these devices. Cost efficiency of non-implantable and wearable electrical stimulation devices is benefitting both patients and med-tech companies.
Market Segmentation: Continence Care Market
Regional Overview: Continence Care Market
Some of the prominent players in the Continence Care Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Continence Care market
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Continence Care Market Study:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Continence Care Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Continence Care Market Analysis and Forecast, 2017–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Reimbursement Scenario, by Region/globally
5.4. Key Industrial Events (licensing partnership/merger & acquisition)
5.5. COVID-19 Impact Analysis
5.6. Porter’s Five Force Analysis
6. Global Continence Care Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2030
6.3.1. Urinary Catheters
6.3.1.1. External Catheters
6.3.1.2. Indwelling Catheters
6.3.1.3. Intermittent Catheters
6.3.1.4. Catheter Accessories
6.3.2. Male Bodyworn Urinals
6.3.3. Mechanical Devices for Women with Urinary Incontinence
6.3.3.1. Urethral Inserts
6.3.3.2. Intravaginal Devices
6.3.4. Urine Drainage Bags & Accessories
6.3.4.1. Leg Drainage Bags
6.3.4.2. Night Drainage Bags
6.3.4.3. Accessories
6.3.5. Absorbents
6.3.6. Penile Clamps
6.3.7. Non-implantable Electrical Stimulation Devices
6.3.8. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Continence Care Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2030
7.3.1. Urge Urinary Incontinence (UUI)
7.3.2. Stress Urinary Incontinence (SUI)
7.3.3. Mixed Urinary Incontinence (MUI)
7.3.4. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Continence Care Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2030
8.3.1. Acute Care Facilities
8.3.2. Long Term Care Facilities
8.3.3. Homecare
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Continence Care Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Continence Care Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2030
10.2.1. Urinary Catheters
10.2.1.1. External Catheters
10.2.1.2. Indwelling Catheters
10.2.1.3. Intermittent Catheters
10.2.1.4. Catheter Accessories
10.2.2. Male Bodyworn Urinals
10.2.3. Mechanical Devices for Women with Urinary Incontinence
10.2.3.1. Urethral Inserts
10.2.3.2. Intravaginal Devices
10.2.4. Urine Drainage Bags & Accessories
10.2.4.1. Leg Drainage Bags
10.2.4.2. Night Drainage Bags
10.2.4.3. Accessories
10.2.5. Absorbents
10.2.6. Penile Clamps
10.2.7. Non-implantable Electrical Stimulation Devices
10.2.8. Others
10.3. Market Value Forecast, by Indication, 2017–2030
10.3.1. Urge Urinary Incontinence (UUI)
10.3.2. Stress Urinary Incontinence (SUI)
10.3.3. Mixed Urinary Incontinence (MUI)
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2030
10.4.1. Acute Care Facilities
10.4.2. Long Term Care Facilities
10.4.3. Homecare
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2030
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Continence Care Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2030
11.2.1. Urinary Catheters
11.2.1.1. External Catheters
11.2.1.2. Indwelling Catheters
11.2.1.3. Intermittent Catheters
11.2.1.4. Catheter Accessories
11.2.2. Male Bodyworn Urinals
11.2.3. Mechanical Devices for Women with Urinary Incontinence
11.2.3.1. Urethral Inserts
11.2.3.2. Intravaginal Devices
11.2.4. Urine Drainage Bags & Accessories
11.2.4.1. Leg Drainage Bags
11.2.4.2. Night Drainage Bags
11.2.4.3. Accessories
11.2.5. Absorbents
11.2.6. Penile Clamps
11.2.7. Non-implantable Electrical Stimulation Devices
11.2.8. Others
11.3. Market Value Forecast, by Indication, 2017–2030
11.3.1. Urge Urinary Incontinence (UUI)
11.3.2. Stress Urinary Incontinence (SUI)
11.3.3. Mixed Urinary Incontinence (MUI)
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2030
11.4.1. Acute Care Facilities
11.4.2. Long Term Care Facilities
11.4.3. Homecare
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-Region, 2017–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-Region
12. Asia Pacific Continence Care Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2030
12.2.1. Urinary Catheters
12.2.1.1. External Catheters
12.2.1.2. Indwelling Catheters
12.2.1.3. Intermittent Catheters
12.2.1.4. Catheter Accessories
12.2.2. Male Bodyworn Urinals
12.2.3. Mechanical Devices for Women with Urinary Incontinence
12.2.3.1. Urethral Inserts
12.2.3.2. Intravaginal Devices
12.2.4. Urine Drainage Bags & Accessories
12.2.4.1. Leg Drainage Bags
12.2.4.2. Night Drainage Bags
12.2.4.3. Accessories
12.2.5. Absorbents
12.2.6. Penile Clamps
12.2.7. Non-implantable Electrical Stimulation Devices
12.2.8. Others
12.3. Market Value Forecast, by Indication, 2017–2030
12.3.1. Urge Urinary Incontinence (UUI)
12.3.2. Stress Urinary Incontinence (SUI)
12.3.3. Mixed Urinary Incontinence (MUI)
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2030
12.4.1. Acute Care Facilities
12.4.2. Long Term Care Facilities
12.4.3. Homecare
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-Region, 2017–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-Region
13. Latin America Continence Care Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2030
13.2.1. Urinary Catheters
13.2.1.1. External Catheters
13.2.1.2. Indwelling Catheters
13.2.1.3. Intermittent Catheters
13.2.1.4. Catheter Accessories
13.2.2. Male Bodyworn Urinals
13.2.3. Mechanical Devices for Women with Urinary Incontinence
13.2.3.1. Urethral Inserts
13.2.3.2. Intravaginal Devices
13.2.4. Urine Drainage Bags & Accessories
13.2.4.1. Leg Drainage Bags
13.2.4.2. Night Drainage Bags
13.2.4.3. Accessories
13.2.5. Absorbents
13.2.6. Penile Clamps
13.2.7. Non-implantable Electrical Stimulation Devices
13.2.8. Others
13.3. Market Value Forecast, by Indication, 2017–2030
13.3.1. Urge Urinary Incontinence (UUI)
13.3.2. Stress Urinary Incontinence (SUI)
13.3.3. Mixed Urinary Incontinence (MUI)
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2030
13.4.1. Acute Care Facilities
13.4.2. Long Term Care Facilities
13.4.3. Homecare
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-Region, 2017–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-Region
14. Middle East & Africa Continence Care Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2030
14.2.1. Urinary Catheters
14.2.1.1. External Catheters
14.2.1.2. Indwelling Catheters
14.2.1.3. Intermittent Catheters
14.2.1.4. Catheter Accessories
14.2.2. Male Bodyworn Urinals
14.2.3. Mechanical Devices for Women with Urinary Incontinence
14.2.3.1. Urethral Inserts
14.2.3.2. Intravaginal Devices
14.2.4. Urine Drainage Bags & Accessories
14.2.4.1. Leg Drainage Bags
14.2.4.2. Night Drainage Bags
14.2.4.3. Accessories
14.2.5. Absorbents
14.2.6. Penile Clamps
14.2.7. Non-implantable Electrical Stimulation Devices
14.2.8. Others
14.3. Market Value Forecast, by Indication, 2017–2030
14.3.1. Urge Urinary Incontinence (UUI)
14.3.2. Stress Urinary Incontinence (SUI)
14.3.3. Mixed Urinary Incontinence (MUI)
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2030
14.4.1. Acute Care Facilities
14.4.2. Long Term Care Facilities
14.4.3. Homecare
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-Region, 2017–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-Region
15. Competitive Landscape
15.1. Market Share Analysis of Key Companies, by Region (2020)
15.2. Company Profiles
15.2.1. Abena A/S
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. Atlantic Therapeutics
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. Attends Healthcare Products, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4. B. Braun Melsungen AG
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Beambridge Medical Ltd.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Becton, Dickinson and Company
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Boston Scientific Corporation
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. Coloplast A/S
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. ConvaTec Group PLC
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Drylock Technologies
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Strategic Overview
15.2.10.4. SWOT Analysis
15.2.11. Hollister Incorporated
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. Strategic Overview
15.2.11.4. SWOT Analysis
15.2.12. InControl Medical LLC
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Product Portfolio
15.2.12.3. Strategic Overview
15.2.12.4. SWOT Analysis
15.2.13. Kimberly-Clark Corporation
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Product Portfolio
15.2.13.3. Financial Overview
15.2.13.4. Strategic Overview
15.2.13.5. SWOT Analysis
15.2.14. Optimum Medical Limited
15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.14.2. Product Portfolio
15.2.14.3. Strategic Overview
15.2.14.4. SWOT Analysis
15.2.15. Pacey MedTech Ltd.
15.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.15.2. Product Portfolio
15.2.15.3. Strategic Overview
15.2.15.4. SWOT Analysis
15.2.16. Renew Medical, Inc.
15.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.16.2. Product Portfolio
15.2.16.3. Strategic Overview
15.2.16.4. SWOT Analysis
15.2.17. Uresta
15.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.17.2. Product Portfolio
15.2.17.3. Strategic Overview
15.2.17.4. SWOT Analysis
15.2.18. Urocare Products, Inc.
15.2.18.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.18.2. Product Portfolio
15.2.18.3. Strategic Overview
15.2.18.4. SWOT Analysis
15.2.19. Vesiflo, Inc.
15.2.19.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.19.2. Product Portfolio
15.2.19.3. Strategic Overview
15.2.19.4. SWOT Analysis